Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
- 1 September 2014
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 26 (3), 402-413
- https://doi.org/10.1016/j.ccr.2014.07.007
Abstract
No abstract availableFunding Information
- Department of Energy
- the NIH, the National Institute of General Medical Sciences, and the National Center for Research Resources
This publication has 63 references indexed in Scilit:
- Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signallingThe EMBO Journal, 2012
- RAF Inhibitor-Induced KSR1/B-RAF Binding and Its Effects on ERK Cascade SignalingCurrent Biology, 2011
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaNature, 2010
- Protein Kinase−Inhibitor Database: Structural Variability of and Inhibitor Interactions with the Protein Kinase P-LoopJournal of Proteome Research, 2010
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAFNature, 2010
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAFCell, 2010
- A dimerization-dependent mechanism drives RAF catalytic activationNature, 2009
- Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibitionNature Structural & Molecular Biology, 2004
- The RAF proteins take centre stageNature Reviews Molecular Cell Biology, 2004
- Mutations of the BRAF gene in human cancerNature, 2002